Moody’s also affirmed the “P-2” short-term rating on CHI’s commercial paper backed by self-liquidity.
The ratings downgrades are based on a number of factors, including CHI’s continued weak operating performance across multiple markets and an increase in the health system’s short-term debt which further pressures its liquidity needs.
The outlook is negative, reflecting CHI’s persistent decline in operating performance since 2012.
More articles on healthcare finance:
Moody’s downgrades Peninsula Regional Medical Center’s rating to ‘A3’
Moody’s withdraws rating on Conway Medical Center’s bonds
Fitch affirms ‘A+’ rating on Palomar Health’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
